Connecting you to content on EBSCOhost

Works matching AU Sola, Piyong

Results: 5

1

Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson's disease management.

Published in:

Expert Opinion on Drug Delivery, 2020, v. 17, n. 8, p. 1119, doi. 10.1080/17425247.2020.1779218

By:

Sola, Piyong;
Krishnamurthy, Praveen;
Chintamaneni, Pavan Kumar;
Pindiprolu, Sai Kiran S.S;
Kumari, Mamta

Publication type:

Article

2

Herbal Drug Standardization: A Systemic Review.

Published in:

Journal of Drug Delivery & Therapeutics, 2023, v. 13, n. 4, p. 149, doi. 10.22270/jddt.v13i4.6012

By:

Lamichhane, Suman;
Sahariah, Bhargab Jyoti;
Das, Bhaswati;
Khatiwara, Deepika;
Sola, Piyong;
Adhikari, Rudra Prasad;
Gogoi, Bitu;
Alam, Tahid

Publication type:

Article

3

Polysorbate 80 surface modified SLNs of formoterol suppress SNCA gene and mitochondrial oxidative stress in mice model of Parkinson's disease.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46511-3

By:

Sola, Piyong;
Garikapati, Kusuma Kumari;
Krishnamurthy, Praveen Thaggikuppe;
Kumari, Mamta

Publication type:

Article

4

Phosphodiesterase-4 Inhibition in Parkinson's Disease: Molecular Insights and Therapeutic Potential.

Published in:

Cellular & Molecular Neurobiology, 2023, v. 43, n. 6, p. 2713, doi. 10.1007/s10571-023-01349-1

By:

Roy, Dhritiman;
Balasubramanian, Shivaramakrishnan;
Krishnamurthy, Praveen Thaggikuppe;
Sola, Piyong;
Rymbai, Emdormi

Publication type:

Article

5

Roflumilast-loaded nanostructured lipid carriers attenuate oxidative stress and neuroinflammation in Parkinson's disease model.

Published in:

Journal of Drug Targeting, 2025, v. 33, n. 1, p. 127, doi. 10.1080/1061186X.2024.2408724

By:

Roy, Dhritiman;
Balasubramanian, Shivaramakrishnan;
Kunte, Prajwal P.;
Natarajan, Jawahar;
Sola, Piyong;
Rymbai, Emdormi;
R, Praharsh Kumar M.

Publication type:

Article